• BXP, Inc. reported first-quarter 2026 results showing revenue of US$872.15 million and net income of US$101.58 million, and raised its full-year 2026 EPS guidance to US$2.15–US$2.29 per diluted share while issuing second-quarter EPS guidance of US$0.44–US$0.46.
• The company attributed the higher full-year guidance midpoint mainly to gains on asset sales and better-than-expected portfolio performance, underscoring how capital recycling and operating execution are feeding directly into earnings.
• With full-year EPS guidance nudged higher on asset sale gains and portfolio strength, we’ll examine how this update interacts with BXP’s existing investment narrative.

Rare earth metals are the new gold rush. Find out which 33 stocks are leading the charge.

BXP Investment Narrative Recap

To own BXP, you generally need to believe in the long term relevance of premier office and life science assets in coastal gateway cities, even as hybrid work and sector specific softness weigh on leasing. The first quarter beat versus prior EPS guidance and the higher full year 2026 EPS range modestly support the near term earnings catalyst, but they do not remove key risks around leasing up new developments, backfilling move outs, and managing the capital needs of large projects like 343 Madison.

The most relevant recent announcement is BXP’s first quarter 2026 earnings, where revenue reached US$872.15 million and net income was US$101.58 million, lifting diluted EPS to US$0.64. That outturn versus earlier quarterly guidance underpins management’s decision to raise full year EPS guidance, tying the latest outlook directly to realized gains on asset sales and better than expected portfolio performance, rather than to any visible shift yet in structural leasing risks or development related capital pressures.

Yet while guidance is higher today, investors should be aware that occupancy pressure and leasing risks around newly delivered projects could still...

BXP’s narrative projects $3.7 billion revenue and $357.3 million earnings by 2029.

Uncover how BXP's forecasts yield a $69.30 fair value, a 17% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts were only penciling in about 2.8% annual revenue growth and US$278.6 million of earnings by 2029, so this guidance surprise could challenge that more cautious view and invite you to weigh how much confidence you put in slower leasing and development risks versus the potential for better earnings momentum.

Explore 2 other fair value estimates on BXP - why the stock might be worth as much as 40% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your BXP research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free BXP research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate BXP's overall financial health at a glance.

Want Some Alternatives?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 49 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.